Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.
Market Dynamics
Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.
Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2021, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.
Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.
Key features of the study:
This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global tissue banking market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Tissue Banking Market, By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
Global Tissue Banking Market, By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Global Tissue Banking Market, By Region:
North America
By Country:
U.S.
Canada
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Product:
Media and Consumables
Equipment
Cryopreservation Equipment
Quality Control Equipment
Thawing equipment
Others
By Tissue Type:
Bone
Brain & Spinal Cord
Cornea
Heart Valves
Skin
Others
Company Profiles
AbD Serotec*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AMS Biotechnology Limited
BioLife Solutions, Inc.
Beckman Coulter, Inc.
BioCision LLC
BioStorage Technologies, Inc.
Custom BioGenic Systems
Eppendorf AG
EMD Millipore Corporation
Fisher BioServices, Inc.
Genzyme Corporation
Hamilton Company
Merck KGaA
PHC Corporation
Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.